STEK (Stemtech) Growth Rank : 0 (As of Apr. 06, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Stemtech Growth Rank?

Stemtech has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Stemtech Growth Rank Related Terms

Thank you for viewing the detailed overview of Stemtech's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Stemtech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stemtech Corp (OTCPK:STEK) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

4851 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103

Website

https://www.stemtech.com

Stemtech Corp is a nutraceutical company. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where perform their daily function of renewal for optimal health. It markets its products under the following brands: RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze. Geographically, it derives a majority of its revenue from the Americas.

Executives

Charles Stuart Arnold	director	520 BRICKELL KEY DR #1607, MIAMI FL 33131
Mindshare Holdings, Inc.	10 percent owner	419 BOSTWICK LANE, GAITHERSBURG MD 20878
Darryl V Green	director	300 SIXTH AVENUE, PITTSBURGH PA 15222
John William Meyer	director	10370 USA TODAY WAY, MIRAMAR FL 33025
Benjamin Nathaniel Kaplan	director	13005 CORONOADO LANE, NORTH MIAMI FL 33181